Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Natrum Sulphuricum
Brand Name
Schuessler Tissue Salts Nat Sulph Water Eliminator 11
Generic Name
Natrum Sulphuricum
Active Ingredient
Sodium Sulfate AnhydrousCategory
Osmotic Laxative [EPC]
Variants
2
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Schuessler Tissue Salts Nat Sulph Water Eliminator 11, you must consult a qualified healthcare professional.
Detailed information about Schuessler Tissue Salts Nat Sulph Water Eliminator 11
Sodium Sulfate Anhydrous is a potent osmotic laxative primarily utilized in clinical settings for rapid and thorough bowel cleansing prior to colonoscopy or surgical procedures.
For colonoscopy preparation, Sodium Sulfate Anhydrous is administered as part of a specific regimen. The dosage is not standardized by weight but rather by the specific product formulation (e.g., solution vs. tablets).
The safety and efficacy of Sodium Sulfate Anhydrous combination products have generally not been established in pediatric patients under the age of 12 or 18, depending on the specific brand. For children requiring bowel preparation, healthcare providers typically use weight-based polyethylene glycol (PEG) solutions instead. Do not administer this medication to a child unless specifically directed by a pediatric specialist.
Sodium Sulfate Anhydrous should be used with extreme caution in patients with impaired renal function (creatinine clearance < 30 mL/min). While the dose is usually not 'reduced' (as the goal is still total bowel clearance), these patients require intensive monitoring of electrolytes and hydration status. In cases of end-stage renal disease, it may be contraindicated.
Specific dosage adjustments are generally not required for patients with liver disease, as the drug is not metabolized by the liver. However, patients with cirrhosis and ascites are at higher risk for fluid shifts and should be monitored closely.
Patients over the age of 65 are at a higher risk for dehydration and orthostatic hypotension (dizziness upon standing). While the standard dose is used, healthcare providers often emphasize a more gradual intake of the required supplemental water.
Proper administration is critical for both the safety and the success of the procedure.
If you miss a dose of the bowel prep, contact your gastroenterologist's office immediately. Timing is crucial for colonoscopy preparation. If the second dose is taken too late, the procedure may need to be rescheduled because the bowel will not be clear in time. Do not double the dose to 'catch up' without medical advice.
An overdose of Sodium Sulfate Anhydrous primarily manifests as profound diarrhea, leading to severe dehydration and electrolyte imbalances.
In the event of a suspected overdose or if the patient cannot keep up with fluid loss due to vomiting, emergency medical attention is required. Treatment involves intravenous (IV) fluid replacement and electrolyte stabilization.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or skip the supplemental water without medical guidance.
Because Sodium Sulfate Anhydrous is designed to induce rapid bowel emptying, certain gastrointestinal symptoms are expected and occur in the majority of patients. These are typically transient and resolve once the bowel is cleared.
Sodium Sulfate Anhydrous is a potent clinical tool that requires strict adherence to safety protocols. The most significant risk associated with this medication is the development of clinically significant fluid and electrolyte abnormalities. These abnormalities can lead to serious complications, including cardiac arrhythmias, seizures, and renal failure. Patients must be hemodynamically stable (have stable blood pressure and heart rate) before starting the preparation.
No FDA black box warnings for Sodium Sulfate Anhydrous. Unlike older phosphate-based laxatives, sulfate-based laxatives have a more favorable safety profile regarding kidney calcification, though they still require caution in at-risk populations.
Sodium Sulfate Anhydrous should not be used concurrently with other osmotic or stimulant laxatives. Combining these can lead to additive fluid loss and increase the risk of bowel perforation or severe electrolyte depletion.
In certain clinical scenarios, the use of Sodium Sulfate Anhydrous is strictly prohibited due to the risk of life-threatening complications.
Pregnancy Category C (Historical): There are no adequate and well-controlled studies of Sodium Sulfate Anhydrous in pregnant women. Animal reproduction studies have not been conducted. It is unknown whether the drug can cause fetal harm or affect reproduction capacity. Because the drug is minimally absorbed, the direct risk to the fetus is likely low; however, the maternal risks of severe dehydration and electrolyte imbalance could indirectly affect fetal well-being. It should be used during pregnancy only if clearly needed and under strict medical supervision.
It is not known whether the components of Sodium Sulfate Anhydrous are excreted in human milk. However, because systemic absorption of the sulfate ions is very limited, the amount expected to reach breast milk is negligible. The primary concern for a nursing mother is maintaining adequate hydration to ensure milk supply is not affected by the bowel prep process.
As of 2026, the use of most Sodium Sulfate Anhydrous combination products is not recommended for patients under 12 years of age. Some specific formulations are restricted to those 18 and older. Pediatric patients are at a much higher risk for rapid dehydration and electrolyte shifts due to their smaller body mass. If a child requires a colonoscopy, specialized pediatric preparations (often PEG-based) are the standard of care.
Sodium Sulfate Anhydrous (Na2SO4) functions as a non-absorbable osmotic agent. The sulfate anion (SO4^2-) is divalent and carries a high charge density, which prevents it from easily crossing the lipid bilayer of the intestinal epithelial cells. This creates a powerful osmotic gradient that 'pulls' water from the interstitial space and the blood into the intestinal lumen. Unlike sodium phosphate, which can be absorbed and cause systemic mineral imbalances, the sulfate ion is largely retained in the gut, making it a safer alternative for many patients.
The pharmacodynamic effect is purely local within the GI tract. The onset of action typically occurs within 1 to 3 hours after the first dose, manifesting as watery diarrhea. The duration of effect lasts until the osmotic load has been expelled, usually 4 to 6 hours after the final dose. There is no evidence of the body developing a 'tolerance' to this mechanism, as it is a physical process rather than a receptor-mediated one.
| Parameter | Value |
|---|---|
Common questions about Schuessler Tissue Salts Nat Sulph Water Eliminator 11
Sodium Sulfate Anhydrous is primarily used as a powerful osmotic laxative to cleanse the colon before a colonoscopy or other medical procedures. It works by drawing a large volume of water into the intestines, which flushes out fecal matter to provide a clear view for the doctor. It is typically found in combination products like SUPREP or SUTAB rather than being used alone. Using this medication ensures that the gastroenterologist can detect polyps or other abnormalities that might be hidden by stool. It is not intended for the treatment of everyday constipation.
The most common side effects include nausea, vomiting, abdominal bloating, and cramping. Because the medication is designed to cause rapid bowel movements, these symptoms are a direct result of the drug's intended action. Most patients find that these effects begin within an hour of taking the dose and subside once the bowel is empty. To manage nausea, doctors often recommend drinking the solution slowly or taking a short break between glasses. If vomiting is severe and you cannot finish the prep, you must contact your healthcare provider immediately.
No, you should not consume alcohol while taking Sodium Sulfate Anhydrous or during the entire bowel preparation process. Alcohol is a diuretic, which means it encourages your body to lose even more fluid, significantly increasing the risk of severe dehydration. Furthermore, alcohol can irritate the gastrointestinal tract and may interfere with the clear liquid diet required for your procedure. It is best to wait until after your procedure and after you have resumed a normal diet and hydration level before consuming alcohol. Always follow the specific dietary instructions provided by your surgical center.
The safety of Sodium Sulfate Anhydrous during pregnancy has not been extensively studied in humans. While the drug itself is minimally absorbed into the bloodstream, the significant fluid and electrolyte shifts it causes could potentially pose a risk to both the mother and the fetus. Most doctors will only perform a colonoscopy during pregnancy if it is absolutely necessary for a serious health issue. If you are pregnant, your healthcare provider will weigh the risks and benefits and may choose a different type of bowel preparation. Always inform your gastroenterologist if there is any possibility that you are pregnant.
Most patients begin to have bowel movements within 1 to 3 hours after drinking the first dose of Sodium Sulfate Anhydrous. However, the exact timing can vary based on your individual digestion and when you last ate. It is essential to stay near a bathroom once you begin the preparation process, as the urge to go can be sudden and frequent. The 'cleansing' process usually continues for several hours after the final dose is taken. By the end of the prep, your bowel movements should be clear or slightly yellowish, similar to urine, indicating the colon is ready.
Sodium Sulfate Anhydrous is taken as a short-term, two-dose regimen, so there is no concern about 'withdrawal' or the need to taper the medication. However, if you stop taking the medication before completing the full prescribed dose, your bowel may not be sufficiently clean for the procedure. This could result in the doctor being unable to see the colon clearly, potentially missing important findings or requiring you to repeat the entire preparation and procedure at a later date. If you are having trouble finishing the prep due to side effects, call your doctor for advice before stopping.
If you miss a dose or fall behind on the timing of your split-dose regimen, contact your doctor's office or the endoscopy center immediately. The timing of the doses is carefully calculated to ensure your bowel is at its cleanest at the exact time of your procedure. If you miss the evening dose, they may have you take it later that night, but if you miss the morning dose, the procedure may need to be rescheduled. Never double the dose to catch up unless specifically instructed to do so by a medical professional. Proper timing is key to a successful exam.
No, Sodium Sulfate Anhydrous does not cause weight gain. In fact, most patients experience a temporary decrease in weight during the preparation process due to the loss of fecal matter and significant fluid volume. This is 'water weight' and is not a reflection of fat loss. Once you resume a normal diet and rehydrate after the procedure, your weight will typically return to its baseline. This medication should never be used as a method for weight loss, as doing so is extremely dangerous and can lead to permanent kidney and heart damage.
Sodium Sulfate Anhydrous can interfere with the absorption of other oral medications because it moves everything through your digestive system very quickly. Generally, you should take other medications at least one hour before starting your bowel prep. However, certain drugs like blood thinners, blood pressure medications, and diabetes drugs require specific management. You must provide your doctor with a full list of your current medications, as some may need to be temporarily paused. For example, your doctor may ask you to stop taking iron supplements or NSAIDs several days before the procedure.
Yes, Sodium Sulfate Anhydrous is available in generic formulations, usually as part of a 'Triple Sulfate' kit (Sodium, Potassium, and Magnesium Sulfates). These generic versions are therapeutically equivalent to brand-name products like SUPREP. The availability of a generic option can significantly reduce the out-of-pocket cost for patients. When your doctor prescribes a bowel prep, the pharmacy will often dispense the generic version unless 'Brand Medically Necessary' is specified. Both the brand and generic versions require the same strict adherence to the clear liquid diet and hydration instructions.
Other drugs with the same active ingredient (Sodium Sulfate Anhydrous)
While rare, serious complications can occur, often related to the rapid shift of fluids and electrolytes between the body's compartments.
> Warning: Stop taking Sodium Sulfate Anhydrous and call your doctor immediately if you experience any of these:
Sodium Sulfate Anhydrous is intended for short-term, acute use. There are no documented long-term side effects when used appropriately for a single procedure. However, chronic misuse (such as for weight loss or chronic constipation) can lead to permanent kidney damage, chronic electrolyte imbalances, and 'cathartic colon,' where the bowel loses its natural ability to contract.
Currently, Sodium Sulfate Anhydrous combination products (like SUPREP or SUTAB) do not carry an FDA Black Box Warning. This is a significant distinction from oral sodium phosphate (OSP) solutions, which carry a Black Box Warning for acute phosphate nephropathy (a form of permanent kidney damage). However, the absence of a Black Box Warning does not mean the drug is without risk; the warnings regarding fluid and electrolyte balance must be strictly followed.
Report any unusual symptoms to your healthcare provider or via the FDA MedWatch program at 1-800-FDA-1088.
For high-risk patients (those with renal failure, heart failure, or those taking diuretics), healthcare providers may require:
While Sodium Sulfate Anhydrous does not have direct sedative effects, the process of bowel preparation often causes significant fatigue, dizziness, and frequent, urgent bathroom trips. It is strongly recommended that patients do not drive or operate heavy machinery while undergoing the preparation process. Furthermore, patients are usually required to have a driver for the procedure itself due to the sedation used during the colonoscopy.
Alcohol should be strictly avoided during the bowel preparation process. Alcohol is a diuretic, which increases the risk of dehydration. It can also irritate the stomach lining and interfere with the clear liquid diet requirements.
If you experience severe abdominal pain, rectal bleeding, or signs of a severe allergic reaction, discontinue the medication immediately and contact your doctor. There is no 'withdrawal' syndrome associated with this drug, as it is used for a single-day course.
> Important: Discuss all your medical conditions, especially heart or kidney problems, with your healthcare provider before starting Sodium Sulfate Anhydrous.
Sodium Sulfate Anhydrous can cause temporary, significant changes in several laboratory values:
For each major interaction, the mechanism is typically pharmacodynamic (the drugs have additive effects on the body's fluid balance) rather than pharmacokinetic (interference with metabolism). The management strategy always involves vigorous hydration and, in some cases, the temporary suspension of the interacting drug.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, heart rhythm, or seizures.
These conditions require a careful risk-benefit analysis by a specialist:
Patients with a known hypersensitivity to any sulfate salts (magnesium sulfate, potassium sulfate) should avoid this medication. It is important to note that a 'sulfate' allergy is chemically distinct from a 'sulfonamide' (sulfa drug) allergy; patients with a sulfa allergy are generally able to take sulfates safely, but they should still inform their doctor.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of stomach or 'gut' problems, before prescribing Sodium Sulfate Anhydrous.
Clinical trials have shown that while the efficacy of Sodium Sulfate Anhydrous is consistent in the elderly, the risk of adverse events is higher. Patients over 65 are more likely to experience:
Healthcare providers often recommend that elderly patients have a caregiver present during the prep to assist with hydration and monitor for falls.
For patients with mild to moderate renal impairment, the drug should be used with caution. The kidneys are responsible for clearing the small amount of sulfate that is absorbed. If renal clearance is slow, sulfate levels can rise, potentially leading to calcium-binding issues. In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, alternative bowel preparations may be considered.
In patients with hepatic impairment, the primary concern is not drug metabolism but the management of fluid. Patients with advanced cirrhosis may have 'third-spacing' of fluids (ascites), and the osmotic draw of the laxative can exacerbate this. Close monitoring of blood pressure and heart rate is advised.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or have underlying kidney or heart conditions.
| Protein Binding | Negligible |
| Half-life | 8.5 hours (for the small absorbed fraction) |
| Tmax | 2 - 4 hours (for absorbed sulfate) |
| Metabolism | None (Inorganic salt) |
| Excretion | Fecal (>95%), Renal (<5%) |
Sodium Sulfate Anhydrous is categorized as an Osmotic Laxative and a Saline Laxative. It is often grouped with other osmotic agents like Polyethylene Glycol (PEG), Magnesium Citrate, and Lactulose. Within the 'Bowel Prep' therapeutic area, it is considered a 'Low-Volume' or 'Ultra-Low Volume' preparation when compared to the 4-liter PEG-electrolyte solutions, which improves patient adherence and satisfaction.